Exhibit 107

CALCULATION OF FILING FEE TABLE

FORM S-8

(Form Type)

SERES THERAPEUTICS, INC.

(Exact Name of Registrant as Specified in its Charter)

Table I: Newly Registered Securities

                 
Plan   Security
Type		  

Security

Class

Title

  

Fee

Calculation
Rule

   Amount
Registered(1)		   Proposed
Maximum
Offering
Price Per
Unit		  

Maximum

Aggregate

Offering

Price

  

Fee

Rate

   Amount of
Registration
Fee
                 
2025 Incentive Award Plan   Equity   Common Stock, par value $0.001 per share   Rule 457(c)
and 457(h)		   479,750(2)   $8.80(3)   $4,221,800   $153.10 per million dollars   $646.36
           
    Total Offering Amounts     $4,221,800     $646.36
           
    Total Fee Offsets         $ —
           
    Net Fee Due               $646.36

 

(1)

In accordance with Rule 416(a) under the Securities Act of 1933, as amended (“Securities Act”), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued under the Seres Therapeutics, Inc. 2025 Incentive Award Plan (the “Incentive Plan”) to prevent dilution resulting from stock splits, stock dividends or similar transactions. In addition, pursuant to Rule 416(c) under the Securities Act, this registration statement also covers an indeterminate amount of interests to be offered or sold pursuant to the Incentive Plan and the ESPP.

(2)

Consists of 479,750 shares of Common Stock that may become issuable under the Incentive Plan pursuant to its terms.

(3)

Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended, and based upon the average of the high and low prices of the Common Stock as reported on the Nasdaq Global Select Market on May 6, 2025.